Exited position

Bill Ackman’s Procter & Gamble (PG) position

Reported position history, portfolio importance and verified filing changes from public SEC disclosures.

Pershing Square Capital ManagementVerified through Q2 2026
Relationship snapshot

At a glance

The full verified relationship, including prior ownership episodes and exits where supported.

First reportedQ2 2012Earliest verified positive filing snapshot
Latest statusExited positionBased on the latest supported relationship state
Peak shares27.95MHighest verified quarter-end share count
Quarters reported7Verified quarters with shares above zero
What happened?

Pershing Square Capital Management first reported Procter & Gamble in Q2 2012. The reported position was increased and reduced across later filings. The latest verified relationship event shows that Pershing Square Capital Management sold the entire position in Q1 2014, and the stock is no longer reported in the latest verified portfolio.

Verified SEC history

Position over time

See the same verified relationship through reported shares, portfolio weight or reported value.

Metric

Gaps indicate periods that cannot be safely connected or where a verified corporate action changes the raw share scale. Stock price, when available, is market context and not a transaction price.

Key filing events

What changed

Latest filing plus the most meaningful reported changes. Unchanged quarters are collapsed by default.

Q1 2014
Sold the entire position−739.61K shares · No shares reported at quarter-end
Q4 2013
Sold 65.2% of the position−1.38M shares · 739.61K shares remained
Filing context

Quarter-end price $81.41 · Estimated holding basis $63.00

Q3 2013
Sold 76.2% of the position−6.82M shares · 2.12M shares remained
Filing context

Quarter-end price $75.59 · Estimated holding basis $63.00

Q2 2013
Sold 68.0% of the position−19.01M shares · 8.94M shares remained
Filing context

Quarter-end price $76.99 · Estimated holding basis $63.00

Q3 2012
Bought 27.5% more+6.03M shares · 27.95M shares reported after the change
Filing context

Quarter-end price $69.36 · Estimated holding basis $63.00

Q2 2012
New position+21.92M shares · 21.92M shares reported
Filing context

Quarter-end price $61.25 · Estimated holding basis $61.25

2 unchanged quarters are collapsed by default.

Portfolio importance

How important was Procter & Gamble in Pershing Square Capital Management’s reported portfolio?

Relative importance is measured only within the verified primary non-option reported portfolio for each quarter.

Last reported portfolio weight0.7%Q4 2013
Last reported rank#7of 7 reported positions
Peak portfolio weight22.9%Q3 2012
Best historical rank#2Q2 2012
At peak importanceQ3 2012
PG
22.9%
Largest holding
23.7%
Cross-investor discovery

Who else owns Procter & Gamble?

Also reported by 4 other tracked investors in their latest verified filings.

Terry SmithFundsmith LLP
PG4.4% of reported portfolio
Ray DalioBridgewater Associates, LP
PG0.1% of reported portfolio
Joel GreenblattGotham Asset Management
PG0.1% of reported portfolio
Explore Procter & Gamble across all tracked investors →
SEC evidence & methodology

SEC filing evidence

Market context and filing-derived values are kept separate from actual transaction prices, which 13F filings do not disclose.

Latest verified stock price$146.392026-09-18

Market context only; not an investor transaction price.

Latest verified investor filingQ2 2026 · filed 2026-08-14
Open SEC filing ↗

View Procter & Gamble stock page →

This tracker follows Pershing Square Capital Management’s Form 13F disclosures. It is not Bill Ackman’s personal brokerage account, and 13F filings do not reveal exact trade dates or execution prices.